https://www.selleckchem.com/pr....oducts/opicapone.htm
Evaluate the cost-effectiveness and difference in length-of-stay when patients in the ED diagnosed with low-risk pulmonary embolism (PE) are managed with early discharge or observation. Single cohort prospective management study from January 2013 to October 2016 of patients with PE diagnosed in the ED and evaluated for a primary composite endpoint of mortality, recurrent venous thromboembolism, and/or major bleeding event at 90days. Low-risk patients had a PE Severity Index score86, no evidence of proximal deep vein thrombosis on
Like
Comment
Share
